152 related articles for article (PubMed ID: 31978379)
1. Very high rate of false positive biochemical results when screening for pheochromocytoma in a large, undifferentiated population with variable indications for testing.
Kline GA; Boyd J; Leung AA; Tang A; Sadrzadeh HM
Clin Biochem; 2020 Mar; 77():26-31. PubMed ID: 31978379
[TBL] [Abstract][Full Text] [Related]
2. Updated reference intervals for urine normetanephrine have no effect on test sensitivity but fewer false positives.
Kline GA; Boyd J; Hyrcza M; Pacaud D; Pasieka JL; Dong Y; Sadrzadeh HSM; Leung AAC
Clin Biochem; 2022 Jan; 99():17-19. PubMed ID: 34626610
[TBL] [Abstract][Full Text] [Related]
3. Inpatient Measurements of Urine Metanephrines are Indistinguishable from Pheochromocytoma: Retrospective Cohort Study.
Kline GA; Boyd J; Sadrzadeh HSM; Leung AA
Am J Med; 2021 Aug; 134(8):1039-1046.e3. PubMed ID: 33864763
[TBL] [Abstract][Full Text] [Related]
4. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
[TBL] [Abstract][Full Text] [Related]
5. A high rate of modestly elevated plasma normetanephrine in a population referred for suspected PPGL when measured in a seated position.
Boyd J; Leung AA; Sadrzadeh HS; Pamporaki C; Pacak K; Deutschbein T; Fliedner S; Kline GA
Eur J Endocrinol; 2019 Sep; 181(3):301-309. PubMed ID: 31370003
[TBL] [Abstract][Full Text] [Related]
6. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
Goupil R; Fountoulakis S; Gordon RD; Stowasser M
J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433
[TBL] [Abstract][Full Text] [Related]
7. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
[TBL] [Abstract][Full Text] [Related]
8. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G
Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytoma: Positive predictive values of mildly elevated urinary fractionated metanephrines in a large cohort of community-dwelling patients.
Hirsch D; Grossman A; Nadler V; Alboim S; Tsvetov G
J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1527-1533. PubMed ID: 31486577
[TBL] [Abstract][Full Text] [Related]
10. Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study.
Takekoshi K; Satoh F; Tanabe A; Okamoto T; Ichihara A; Tsuiki M; Katabami T; Nomura M; Tanaka T; Matsuda T; Imai T; Yamada M; Asada S; Kawata N; Naruse M
Endocr J; 2019 Dec; 66(12):1063-1072. PubMed ID: 31511435
[TBL] [Abstract][Full Text] [Related]
11. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
[TBL] [Abstract][Full Text] [Related]
12. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
van Berkel A; Lenders JW; Timmers HJ
Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
[TBL] [Abstract][Full Text] [Related]
14. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
[TBL] [Abstract][Full Text] [Related]
15. Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine.
Remde H; Pamporaki C; Quinkler M; Nölting S; Prejbisz A; Timmers HJLM; Masjkur J; Fuss CT; Fassnacht M; Eisenhofer G; Deutschbein T
Hypertension; 2022 Jun; 79(6):1257-1264. PubMed ID: 35378989
[TBL] [Abstract][Full Text] [Related]
16. Hypertensive emergency masquerading as phaeochromocytoma: a report of two cases.
Hulkower R; Gubbi S; Meholli M; Schubart U
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784870
[TBL] [Abstract][Full Text] [Related]
17. Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma.
Eugster PJ; Maurer J; Vocat C; Abid K; Matter M; Wuerzner G; Trepp R; Fischli S; Henzen C; Kolb W; Bilz S; Sigrist S; Beuschlein F; Nölting S; Reul A; Schütze I; Hubers SA; Brown NJ; Grouzmann E
Clin Chim Acta; 2022 Sep; 534():146-155. PubMed ID: 35905838
[TBL] [Abstract][Full Text] [Related]
18. Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma.
Eisenhofer G; Peitzsch M; Bechmann N; Huebner A
Front Endocrinol (Lausanne); 2022; 13():901760. PubMed ID: 35957826
[TBL] [Abstract][Full Text] [Related]
19. Plasma Metanephrines Yield Fewer False-Positive Results Than Urine Metanephrines in Patients With Obstructive Sleep Apnea.
King TFJ; Mok Y; Dacay LM; Wong HS; Hsu PP; Tan A; Wong KM; Saffari SE; Lenders JWM; Puar TH
J Clin Endocrinol Metab; 2024 Feb; 109(3):844-851. PubMed ID: 37721483
[TBL] [Abstract][Full Text] [Related]
20. Biochemical Assessment of Pheochromocytoma and Paraganglioma.
Eisenhofer G; Pamporaki C; Lenders JWM
Endocr Rev; 2023 Sep; 44(5):862-909. PubMed ID: 36996131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
